Cooper, D. (2018) “A POPULATION-BASED COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE AND RISPERIDONE AMONG AMBULATORY PATIENTS WITH SCHIZOPHRENIA”, Journal of Population Therapeutics and Clinical Pharmacology, 15(3). Available at: https://jptcp.com/index.php/jptcp/article/view/229 (Accessed: 11 September 2025).